Abstract Library

#1702 Comparative Retrospective Analysis of pNETs Treatment with Everolimus (E) and Sunitinib (S).

Introduction: Two targeted compounds are validated for treatment of pNETs – E and S.

Conference: 14th Annual ENETSConcerence (2017)

Presenting Author:

Authors: Kouzminov A, Odintsova A, Polozkova S, Orel N, Markovich A,

Keywords: pNETs, sunitinib, everolimus,

#1294 The Efficacy and Safety of Sunitinib in Heavily Pretreated Patients with NETs. National Cancer Research Center Experience.

Introduction: There was done monocentral trial. 19 pts with progressive well differentiated NETs (G1,G2) were treated with sunitinib

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Odintsova A, Gorbunova V, Orel N, Markovich A, Kouzminov A,

Keywords: NET, sunitinib,efficacy,chemotherapy,

#1275 Aranoza in the Treatment of Metastatic Neuroendocrine Tumors (NETs): Single Institution Experience

Introduction: Aranoza (3-α-L-arabinopyranosyl-1-methyl-nitrosourea) – nitrosourea derivative, as STZ.

Conference: 13th Annual ENETSConcerence (2016)

Presenting Author:

Authors: Gorbunova V, Orel N, Kuzminov A, Emelianova G, Odintsova A,

Keywords: aranoza, Neuroendocrine tumors, chemotherapy,

#910 Experience of Temozolomide Mono- and Combination Therapy in Advanced Neuroendocrine Tumors (NETs) in Russia

Introduction: Temozolomide (T) demonstrated promising activity in NETs in numerous phase 2 studies worldwide. But there is not enough data about its efficacy in the Russian population.

Conference: 11th Annual ENETSConcerence (2014)

Presenting Author:

Authors: Gorbunova V, Markovich A, Orel N, Kuzminov A, Odintsova A,

Keywords: temozolomide, neuroendocrine tumors ,

#659 Everolimus in Patients with Previously Treated Metastatic Neuroendocrine Tumors (NETs)

Introduction: Everolimus is the standard of care in well-differentiated NETs. Previous randomized trials included patients treated with a maximum of two lines of prior chemotherapy. We evaluated everolimus in heavily pretreated patients with NETs.

Conference: 10th Annual ENETSConcerence (2013)

Presenting Author:

Authors: Gorbunova V, Orel N, Kuzminov A, Markovich A, Odintsova A,

Keywords: neuroendocrine tumor, everolimus,